Tags : AbCellera

Pharma

AbCellera Signs an Exclusive Multi-Year Agreement with Eli Lilly to

Shots: AbCellera to receive upfront, pre-clinical, clinical & commercial milestones including research payments for the non-COVID-19 targets plus royalties on future sales. Eli Lilly to get rights to develop and commercialize the Abs developed in the collaboration In early 2020, the companies collaborated for multi target agreement focusing to develop Abs for COVID-19 while Eli […]Read More

Insights+

Insights+: COVID-19 Healthcare News Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (March 09-13, 2020)

1. I-Mab to Initiate the Development of TJM2 for Treating Cytokine Release Syndrome Associated with COVID-19 Published: Mar 13, 2020 | Tags: I-Mab, Initiate, Development, TJM2, Treating, Cytokine Release Syndrome, COVID-19 2. EMD Serono and Pfizer to Terminate P-III JAVELIN Head and Neck 100 Study Evaluating Bavencio + CRT for Squamous Cell Carcinoma of the Head […]Read More

Biotech COVID-19

AbCellera and Eli Lilly Collaborate to Co-develop Antibody Therapies Targeting

Shots: The alliance will leverage AbCellera’s rapid pandemic response platform, developed under the DARPA P3 program with Eli Lilly’s development & manufacturing capabilities. The companies will equally share the initial development cost while Lilly will be solely responsible for further development, manufacturing & distribution activities The companies have identified ~500+ unique Ab isolated from one […]Read More

Uncategorized

Insights+ Exclusive: COVID-19 Healthcare News Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

Insights+

Insights+: COVID-19 Healthcare News Updates

Shots: Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019 PharmaShots is keeping a track of all of the important updates in the Lifesciences sector […]Read More

Pharma

AbCellera Signs a Research Agreement with Bill & Melinda Gates

Shots: Bill & Melinda Gates Foundation provides $4.8M fund to AbCellera to develop Ab for infectious diseases including HIV, malaria & tuberculosis The focus of the agreement is to get benefit from AbCellera’s Ab discovery technology and development of vaccines with the improvement in QoL AbCellera’s single-cell screening technology is a combination of live-cell assays […]Read More